Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology

Recent & Breaking News (TSX:CXR.R)

Concordia Healthcare Corp. to Acquire Covis Pharma Commercial Assets for US$1.2 Billion

Canada NewsWire March 9, 2015

Concordia Healthcare Corp. Provides Corporate Update

Canada NewsWire February 12, 2015

Cantech Letter Announces Finalists for 2014 Cantech Letter Awards

Marketwired December 22, 2014

Concordia Healthcare Corp. Announces Change to Board of Directors

Canada NewsWire December 22, 2014

Concordia Healthcare Corp. Provides Clinical Trial and Corporate Update

Canada NewsWire November 28, 2014

Concordia Healthcare Announces Third Quarter Results - Revenue up 147%, EBITDA up 80% Over Comparative Period

Canada NewsWire November 13, 2014

Concordia Healthcare Corp. to host third quarter 2014 results conference call

Canada NewsWire October 23, 2014

Pinnacle Biologics, Inc., a subsidiary of Concordia Healthcare Corp., announces European site initiation of Phase 3 bile duct cancer trial using photodynamic therapy with PHOTOFRIN®

Canada NewsWire October 7, 2014

Concordia Healthcare Corp. Announces Completion of Zonegran® Acquisition

Canada NewsWire September 30, 2014

Concordia Healthcare Announces Agreement to Acquire Zonegran® in the United States and Puerto Rico

Canada NewsWire September 3, 2014

Concordia Healthcare Corp. enters into collaboration agreement with Orphan Canada

Canada NewsWire September 2, 2014

Concordia Healthcare Corp. Announces Financial and Operational Results for its Second Quarter, Ended June 30, 2014

Canada NewsWire August 13, 2014

Concordia Healthcare Corp. announces first patients enrolled in Phase 2 clinical trial using Photodynamic Therapy with PHOTOFRIN(R) for patients with mesothelioma

Canada NewsWire August 11, 2014

Concordia Healthcare Corp. initiates Phase 3 bile duct cancer trial using photodynamic therapy with PHOTOFRIN®

Canada NewsWire August 5, 2014

Concordia Healthcare Corp. to host second quarter 2014 results conference call

Canada NewsWire July 31, 2014

Concordia Healthcare Corp. Reports Results of Annual General and Special Meeting of Shareholders

Canada NewsWire June 27, 2014

Concordia Healthcare to Present at Bloom Burton & Co. Healthcare Investor Conference

Canada NewsWire June 12, 2014

PBM Pharmaceuticals, Inc. Reports Securities Ownership in Concordia Healthcare Corp.

Canada NewsWire May 15, 2014

Concordia Healthcare Announces Successful Completion of Donnatal® Acquisition

Canada NewsWire May 15, 2014

Concordia Healthcare Announces Financial and Operational Results for its First Quarter, Ended March 31, 2014

Canada NewsWire May 15, 2014